T-cell receptor alpha constant (TRAC)

The T-cell receptor alpha constant (TRAC) is a crucial component of the T-cell receptor (TCR) complex, a heterodimeric protein found on the surface of T lymphocytes. It plays an essential role in the adaptive immune response by facilitating the recognition of peptide-major histocompatibility (MHC) complexes presented by antigen-presenting cells. Upon binding to these complexes, the TRAC, as part of the TCR, initiates a complex intracellular signaling cascade involving proteins like LCK, ZAP70, and LAT, ultimately leading to T cell activation, growth, and differentiation. Dysfunction of the TRAC gene can lead to severe primary immunodeficiency disorders, such as Immunodeficiency 7 (IMD7), characterized by a lack of functional TCRαβ+ T cells and increased susceptibility to infections and immune dysregulation. While not a direct antigen-binding site, the TRAC region is vital for the structural integrity and proper assembly of the TCR. In therapeutic contexts, particularly in cancer immunotherapy, the TRAC locus is a target for engineering T cells. Strategies like TCR-engineered T cells (TCR-T therapy) and HLA-independent T-cell (HIT) receptors involve modifying or inserting genes into the TRAC locus to enhance tumor recognition and cytotoxic activity. However, these approaches face challenges such as off-target toxicity, undesired mixed dimer formation with endogenous TCRs, and HLA restriction, necessitating careful design and safety assessments.

Other names

TCRAT Cell Receptor Alpha Chain ConstantTRAIMD7TRCA